Preventative effects of morinda citrifolia on mammary breast cancer
United States Patent Application 20050037101
The present invention features a novel use of processed ingredients from the Indian mulberry plant. More specifically, the present invention features a novel use of processed Morinda citrifolia, namely Morinda citrifolia fruit juice, puree, or puree juice for treating breast cancer, and particularly for inhibiting and/or preventing the metastasis of carcinogenic cells within the mammary region of the breast, as well as destroying metastasized mammary or breast cancer cells. The present invention comprises the consumption of food products or medicinal products or compositions comprising processed Morinda citrifolia, in either puree or fruit juice form. The present invention also features a method of inhibiting carcinogen-mediated conversion of mammary cells and protecting DNA against carcinogen-mediated damage by administering a composition comprising water soluble Morinda citrifolia.
Morinda citrifolia Based Formulations for Regulating T cell Immunomodulation in Neonatal Stock Animals
United States Patent Application 20090068204
Both liquid and dry form Morinda citrifolia enhanced animal food products are provided for increasing CD8+ T cell activation in new born animals. Both contain M. citrifolia fruit puree and other M. citrifolia plant products.
Anti-angiogenesis effects of morinda citrifolia
United States Patent Application 20040086583
The present invention features a method of inducing an anti-angiogenesis effect within a tumorous region in the body of a mammal, wherein the method comprises the steps of administering, to a patient, a formulation comprising processed Morinda Citrifolia, wherein the processed Morinda citrifolia blocks formation of new blood vessels within a tumorous region by inhibiting tubule elongation and endothelial cell migration. Blocking the growth factors of said endothelial cells within said tumorous region inhibits tubule elongation and endothelial cell migration. In a preferred embodiment, the processed Morinda citrifolia comprises fruit juice and puree juice in various concentrations.
Morinda citrifolia enhanced lip treatment
United States Patent Application 20030086989
The present invention provides a lip treatment formulated with Morinda citrifolia juice or oil. The Morinda citrifolia lip treatment of the present invention serves to provide significant health and lip care advantages.
Method for treating carbon tetra-cloride induced liver damage by administering morinda citrifolia
United States Patent Application 20030086990
There is disclosed a method for preventing CCL4 (carbon tetracloride) induced liver damage comprising the prophylactic administration of extracts of Morinda citrifolia. The Morinda citrifolia may be administered in solid or liquid forms. Several regimens are disclosed including the administration of 2 ounces twice daily in a liquid form such as that sold by Morinda, Inc.
Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells
United States Patent Application 20050106275
The present invention features processed ingredients from the Indian mulberry plant, and particularly Morinda citrifolia fruit juice, for inhibiting and preventing metastasis of carcinogenic cells, as well as destroying metastasized cells. At least some implementations of the present invention comprise the consumption of food products or medicinal products or compositions comprising processed Morinda citrifolia.
Preventative and treatment effects of morinda citrifolia on osteoarthritis and its related conditions
United States Patent Application 20030108631
The present invention embraces methods for improved treatment of osteoarthritis by featuring a naturaceutical formulation or composition for treating osteoarthritis and its associated or related conditions. The present invention further features methods of treating osteoarthritis and its related conditions. In particular, the present invention relates to providing a treatment for osteoarthritis that includes one or more processed products described below as derived and produced from the Indian Mulberry plant, scientifically known as Morinda citrifolia L.
Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions
United States Patent Application 20050147700
The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.
Inhibitory and preventative effects of processed morinda citrifolia on mutagenesis and carcinogenesis in mammals
United States Patent Application 20030157205
The present invention features a method for inhibiting, reducing, and/or preventing mutagenesis, or inducing antimutagenesis activity, through the prophylactic administration of a naturaceutical formulation comprising at least one of a processed Morinda citrifolia product. The present invention seeks to provide a natural composition, or naturaceutical, for the purpose of inhibiting both naturally occurring or spontaneous mutagenesis, as well as environmentally induced mutagenesis, within the body of a mammal.
Method and formulation for treating Candidiasis using Morinda citrifolia
United States Patent Application 20060159788
The present invention features a novel use of processed ingredients from the Indian mulberry plant, and particularly a novel use of one or more processed Morinda citrifolia-based naturaceutical formulations comprising one or more of a processed Morinda citrifolia fruit juice, puree juice, oil or oil extract, dietary fiber, alcohol extract, etc., for inhibiting and preventing the overgrowth of Candida fungus and for treating Candidiasis and its associated symptoms.
Method and formulation for treating candidiasis using morinda citrifolia
United States Patent Application 20030161901
The present invention features a novel use of processed ingredients from the Indian mulberry plant, and particularly a novel use of one or more processed Morinda citrifolia-based naturaceutical formulations comprising one or more of a processed Morinda citrifolia fruit juice, puree juice, oil or oil extract, dietary fiber, alcohol extract, etc., for inhibiting and preventing the overgrowth of Candida fungus and for treating Candidiasis and its associated symptoms.
Morinda citrifolia (Noni) enhanced animal food product
United States Patent Application 20020182276
The present invention advances prior art animal food products by providing an animal food product formulated with Morinda Citrifolia, or Noni, from the Indian Mulberry plant. The addition of Noni to the animal food product of the present invention serves to provide significant health advantages not found in prior art animal food products.
Morinda citrifolia-based formulation 5-LOX and 15-LOX
United States Patent Application 20070184135
The present invention is directed to methods and formulations for inhibiting Lipoxygenase enzymes that function to biosynthesize or metabolize arachidonic acid into its intermediate Leukotriene constituents, as well as a method and formulation for treating and preventing diseases, including inflammatory diseases, and the symptoms associated with such diseases. The present invention methods and formulations effectively function as such through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre-determined duration, wherein the processed Morinda citrifolia product may comprise one or more isolated active ingredients.
Morinda citrifolia as a 5-Lipoxygenase inhibitor
United States Patent Application 20040191341
The present invention is directed to methods and formulations for inhibiting Lipoxygenase or Lipoxygenase enzymes that function to biosynthesize or metabolize arachidonic acid into its intermediate Leukotriene constituents, as well as a method and formulation for treating and preventing inflammatory diseases and the symptoms associated with such diseases. The present invention methods and formulations effectively function as such through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre-determined duration, wherein the processed Morinda citrifolia product may comprise one or more isolated active ingredients.
Morinda citrifolia enhanced colon cancer cell growth inhibitor
United States Patent Application 20060193932
The present invention features methods and formulations or compositions for the treatment of colon cancer, and particularly for the inhibition, prevention and/or reduction of cancerous cell growth, as well as the destruction of early stage cancerous cells within the colon region of a mammal, wherein the formulations and compositions comprise an identified amount or concentration of a processed Morinda citrifolia product or an active ingredient there from, as obtained from the Indian Mulberry plant.
Morinda Citrifolia Based Antifungal Formulations and Methods
United States Patent Application 20070196524
The present invention provides a formulation which may be utilized in agricultural practice that is eco-friendly and effective as plant growth promotion agent, soil improvement agent, bactericide and insecticide agent, disease and harmful insect prevention agent, and is suitable for organic farming. The formulation of the present invention is comprised of a Morinda citrifolia product or extract. The formulation of the present invention may be applied to fruit vegetables, leafy vegetables, root vegetables, grains as well as flowers and shrubs, increasing the amount of yield and extending freshness period after harvest. Further, the present invention relates to antifungal and antibacterial activity of processed Morinda citrifolia products, as well as from various fractions of extracts from these processed products and the Morinda citrifolia L. plant, and related methods to determine mean inhibitory concentrations. In particular, the present invention relates to ethanol, methanol and ethyl acetate extracts from Morinda citrifolia L. and their inhibitory activities on common fungi and bacteria and the identification of mean inhibitory concentrations.
Administration of Morinda Citrifolia L. Based Formulations to Increase Birth Rates
United States Patent Application 20080206368
The present invention relates to methods and formulations directed to increasing mammalian birth rates comprising the administration of processed Morinda citrifolia based formulations.
Treatment of Glaucoma and Diabetic Retinopathy with Morinda Citrifolia Enhanced Formulations
United States Patent Application 20080213415
The present invention relates to methods and formulations directed inhibiting carbonic anhydrase, fatty acid amide hydrolase and endothelin-converting enzymes comprising the administration of processed Morinda citrifolia based formulations.
Antifungal effects of Morinda citrifolia
United States Patent Application 20030225005
The present invention relates to antifungal and antibacterial activity of processed Morinda citrifolia products, as well as from various fractions of extracts from these processed products and the Morinda citrifolia L. plant, and related methods to determine mean inhibitory concentrations. In particular, the present invention relates to ethanol, methanol and ethyl acetate extracts from Morinda citrifolia L. and their inhibitory activities on common fungi and bacteria and the identification of mean inhibitory concentrations.
Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX
United States Patent Application 20070281903
The present invention is directed to methods and formulations for inhibiting Lipoxygenase enzymes that function to biosynthesize or metabolize arachidonic acid into its intermediate Leukotriene constituents, as well as a method and formulation for treating and preventing diseases, including inflammatory diseases, and the symptoms associated with such diseases. The present invention methods and formulations effectively function as such through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre-determined duration, wherein the processed Morinda citrifolia product may comprise one or more isolated active ingredients.
Morinda citrifolia oil
United States Patent 6214351
An essential oil product obtained from the Indian mulberry (Morinda citrifolia) plant and the process of extracting and purifying the oil is disclosed. According to one embodiment, the seeds from the Indian mulberry fruit are dried, preferably to a moisture content less than 10%. The seeds are ground or shredded to facilitate the removal of natural occurring oil. The shredded or ground flakes are pressed to expel Morinda citrifolia oil. The remaining seed cake is then mixed with a food grade, non-polar extraction solvent such as hexane. The mixture is heated for a sufficient length of time to complete the extraction process. The extraction solvent is then evaporated from the mixture leaving the Morinda citrifolia oil. The oil is further refined, bleached, dried, and deodorized to remove free fatty acids and other unwanted components. An antioxidant can optionally be added to stabilize the oil for further processing or packaging.
Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions
United States Patent 6855345
The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.
Method and formulation for treating candidiasis using morinda citrifolia
United States Patent 7014873
The present invention features a novel use of processed ingredients from the Indian mulberry plant, and particularly a novel use of one or more processed Morinda citrifolia-based naturaceutical formulations comprising one or more of a processed Morinda citrifolia fruit juice, puree juice, oil or oil extract, dietary fiber, alcohol extract, etc., for inhibiting and preventing the overgrowth of Candida fungus and for treating Candidiasis and its associated symptoms.
Palliative effects of morinda citrifolia oil and juice
United States Patent 7018662
A method of preventing and treating various ailments and diseases by utilizing the Cox-2 selective inhibition characteristics of processed Morinda citrifolia.
Preventative and treatment effects of Morinda citrifolia on osteoarthritis and its related conditions
United States Patent 7033624
The present invention embraces methods for improved treatment of osteoarthritis by featuring a naturaceutical formulation or composition for treating osteoarthritis and its associated or related conditions. The present invention further features methods of treating osteoarthritis and its related conditions. In particular, the present invention relates to providing a treatment for osteoarthritis that includes one or more processed products described below as derived and produced from the Indian Mulberry plant, scientifically known as Morinda citrifolia L.
Formulation for treating candidiasis using Morinda citrifolia
United States Patent 7442395
The present invention features a formulation from the Indian mulberry plant (Morinda citrifolia ) comprising Morinda citrifolia fruit juice, Morinda citrifolia oil, quercetin, Morinda citrifolia puree juice and Morinda citrifolia dietary fiber treating Candidiasis.
sumber :freepatentsonline.com
United States Patent Application 20050037101
The present invention features a novel use of processed ingredients from the Indian mulberry plant. More specifically, the present invention features a novel use of processed Morinda citrifolia, namely Morinda citrifolia fruit juice, puree, or puree juice for treating breast cancer, and particularly for inhibiting and/or preventing the metastasis of carcinogenic cells within the mammary region of the breast, as well as destroying metastasized mammary or breast cancer cells. The present invention comprises the consumption of food products or medicinal products or compositions comprising processed Morinda citrifolia, in either puree or fruit juice form. The present invention also features a method of inhibiting carcinogen-mediated conversion of mammary cells and protecting DNA against carcinogen-mediated damage by administering a composition comprising water soluble Morinda citrifolia.
Morinda citrifolia Based Formulations for Regulating T cell Immunomodulation in Neonatal Stock Animals
United States Patent Application 20090068204
Both liquid and dry form Morinda citrifolia enhanced animal food products are provided for increasing CD8+ T cell activation in new born animals. Both contain M. citrifolia fruit puree and other M. citrifolia plant products.
Anti-angiogenesis effects of morinda citrifolia
United States Patent Application 20040086583
The present invention features a method of inducing an anti-angiogenesis effect within a tumorous region in the body of a mammal, wherein the method comprises the steps of administering, to a patient, a formulation comprising processed Morinda Citrifolia, wherein the processed Morinda citrifolia blocks formation of new blood vessels within a tumorous region by inhibiting tubule elongation and endothelial cell migration. Blocking the growth factors of said endothelial cells within said tumorous region inhibits tubule elongation and endothelial cell migration. In a preferred embodiment, the processed Morinda citrifolia comprises fruit juice and puree juice in various concentrations.
Morinda citrifolia enhanced lip treatment
United States Patent Application 20030086989
The present invention provides a lip treatment formulated with Morinda citrifolia juice or oil. The Morinda citrifolia lip treatment of the present invention serves to provide significant health and lip care advantages.
Method for treating carbon tetra-cloride induced liver damage by administering morinda citrifolia
United States Patent Application 20030086990
There is disclosed a method for preventing CCL4 (carbon tetracloride) induced liver damage comprising the prophylactic administration of extracts of Morinda citrifolia. The Morinda citrifolia may be administered in solid or liquid forms. Several regimens are disclosed including the administration of 2 ounces twice daily in a liquid form such as that sold by Morinda, Inc.
Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells
United States Patent Application 20050106275
The present invention features processed ingredients from the Indian mulberry plant, and particularly Morinda citrifolia fruit juice, for inhibiting and preventing metastasis of carcinogenic cells, as well as destroying metastasized cells. At least some implementations of the present invention comprise the consumption of food products or medicinal products or compositions comprising processed Morinda citrifolia.
Preventative and treatment effects of morinda citrifolia on osteoarthritis and its related conditions
United States Patent Application 20030108631
The present invention embraces methods for improved treatment of osteoarthritis by featuring a naturaceutical formulation or composition for treating osteoarthritis and its associated or related conditions. The present invention further features methods of treating osteoarthritis and its related conditions. In particular, the present invention relates to providing a treatment for osteoarthritis that includes one or more processed products described below as derived and produced from the Indian Mulberry plant, scientifically known as Morinda citrifolia L.
Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions
United States Patent Application 20050147700
The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.
Inhibitory and preventative effects of processed morinda citrifolia on mutagenesis and carcinogenesis in mammals
United States Patent Application 20030157205
The present invention features a method for inhibiting, reducing, and/or preventing mutagenesis, or inducing antimutagenesis activity, through the prophylactic administration of a naturaceutical formulation comprising at least one of a processed Morinda citrifolia product. The present invention seeks to provide a natural composition, or naturaceutical, for the purpose of inhibiting both naturally occurring or spontaneous mutagenesis, as well as environmentally induced mutagenesis, within the body of a mammal.
Method and formulation for treating Candidiasis using Morinda citrifolia
United States Patent Application 20060159788
The present invention features a novel use of processed ingredients from the Indian mulberry plant, and particularly a novel use of one or more processed Morinda citrifolia-based naturaceutical formulations comprising one or more of a processed Morinda citrifolia fruit juice, puree juice, oil or oil extract, dietary fiber, alcohol extract, etc., for inhibiting and preventing the overgrowth of Candida fungus and for treating Candidiasis and its associated symptoms.
Method and formulation for treating candidiasis using morinda citrifolia
United States Patent Application 20030161901
The present invention features a novel use of processed ingredients from the Indian mulberry plant, and particularly a novel use of one or more processed Morinda citrifolia-based naturaceutical formulations comprising one or more of a processed Morinda citrifolia fruit juice, puree juice, oil or oil extract, dietary fiber, alcohol extract, etc., for inhibiting and preventing the overgrowth of Candida fungus and for treating Candidiasis and its associated symptoms.
Morinda citrifolia (Noni) enhanced animal food product
United States Patent Application 20020182276
The present invention advances prior art animal food products by providing an animal food product formulated with Morinda Citrifolia, or Noni, from the Indian Mulberry plant. The addition of Noni to the animal food product of the present invention serves to provide significant health advantages not found in prior art animal food products.
Morinda citrifolia-based formulation 5-LOX and 15-LOX
United States Patent Application 20070184135
The present invention is directed to methods and formulations for inhibiting Lipoxygenase enzymes that function to biosynthesize or metabolize arachidonic acid into its intermediate Leukotriene constituents, as well as a method and formulation for treating and preventing diseases, including inflammatory diseases, and the symptoms associated with such diseases. The present invention methods and formulations effectively function as such through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre-determined duration, wherein the processed Morinda citrifolia product may comprise one or more isolated active ingredients.
Morinda citrifolia as a 5-Lipoxygenase inhibitor
United States Patent Application 20040191341
The present invention is directed to methods and formulations for inhibiting Lipoxygenase or Lipoxygenase enzymes that function to biosynthesize or metabolize arachidonic acid into its intermediate Leukotriene constituents, as well as a method and formulation for treating and preventing inflammatory diseases and the symptoms associated with such diseases. The present invention methods and formulations effectively function as such through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre-determined duration, wherein the processed Morinda citrifolia product may comprise one or more isolated active ingredients.
Morinda citrifolia enhanced colon cancer cell growth inhibitor
United States Patent Application 20060193932
The present invention features methods and formulations or compositions for the treatment of colon cancer, and particularly for the inhibition, prevention and/or reduction of cancerous cell growth, as well as the destruction of early stage cancerous cells within the colon region of a mammal, wherein the formulations and compositions comprise an identified amount or concentration of a processed Morinda citrifolia product or an active ingredient there from, as obtained from the Indian Mulberry plant.
Morinda Citrifolia Based Antifungal Formulations and Methods
United States Patent Application 20070196524
The present invention provides a formulation which may be utilized in agricultural practice that is eco-friendly and effective as plant growth promotion agent, soil improvement agent, bactericide and insecticide agent, disease and harmful insect prevention agent, and is suitable for organic farming. The formulation of the present invention is comprised of a Morinda citrifolia product or extract. The formulation of the present invention may be applied to fruit vegetables, leafy vegetables, root vegetables, grains as well as flowers and shrubs, increasing the amount of yield and extending freshness period after harvest. Further, the present invention relates to antifungal and antibacterial activity of processed Morinda citrifolia products, as well as from various fractions of extracts from these processed products and the Morinda citrifolia L. plant, and related methods to determine mean inhibitory concentrations. In particular, the present invention relates to ethanol, methanol and ethyl acetate extracts from Morinda citrifolia L. and their inhibitory activities on common fungi and bacteria and the identification of mean inhibitory concentrations.
Administration of Morinda Citrifolia L. Based Formulations to Increase Birth Rates
United States Patent Application 20080206368
The present invention relates to methods and formulations directed to increasing mammalian birth rates comprising the administration of processed Morinda citrifolia based formulations.
Treatment of Glaucoma and Diabetic Retinopathy with Morinda Citrifolia Enhanced Formulations
United States Patent Application 20080213415
The present invention relates to methods and formulations directed inhibiting carbonic anhydrase, fatty acid amide hydrolase and endothelin-converting enzymes comprising the administration of processed Morinda citrifolia based formulations.
Antifungal effects of Morinda citrifolia
United States Patent Application 20030225005
The present invention relates to antifungal and antibacterial activity of processed Morinda citrifolia products, as well as from various fractions of extracts from these processed products and the Morinda citrifolia L. plant, and related methods to determine mean inhibitory concentrations. In particular, the present invention relates to ethanol, methanol and ethyl acetate extracts from Morinda citrifolia L. and their inhibitory activities on common fungi and bacteria and the identification of mean inhibitory concentrations.
Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX
United States Patent Application 20070281903
The present invention is directed to methods and formulations for inhibiting Lipoxygenase enzymes that function to biosynthesize or metabolize arachidonic acid into its intermediate Leukotriene constituents, as well as a method and formulation for treating and preventing diseases, including inflammatory diseases, and the symptoms associated with such diseases. The present invention methods and formulations effectively function as such through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre-determined duration, wherein the processed Morinda citrifolia product may comprise one or more isolated active ingredients.
Morinda citrifolia oil
United States Patent 6214351
An essential oil product obtained from the Indian mulberry (Morinda citrifolia) plant and the process of extracting and purifying the oil is disclosed. According to one embodiment, the seeds from the Indian mulberry fruit are dried, preferably to a moisture content less than 10%. The seeds are ground or shredded to facilitate the removal of natural occurring oil. The shredded or ground flakes are pressed to expel Morinda citrifolia oil. The remaining seed cake is then mixed with a food grade, non-polar extraction solvent such as hexane. The mixture is heated for a sufficient length of time to complete the extraction process. The extraction solvent is then evaporated from the mixture leaving the Morinda citrifolia oil. The oil is further refined, bleached, dried, and deodorized to remove free fatty acids and other unwanted components. An antioxidant can optionally be added to stabilize the oil for further processing or packaging.
Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions
United States Patent 6855345
The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.
Method and formulation for treating candidiasis using morinda citrifolia
United States Patent 7014873
The present invention features a novel use of processed ingredients from the Indian mulberry plant, and particularly a novel use of one or more processed Morinda citrifolia-based naturaceutical formulations comprising one or more of a processed Morinda citrifolia fruit juice, puree juice, oil or oil extract, dietary fiber, alcohol extract, etc., for inhibiting and preventing the overgrowth of Candida fungus and for treating Candidiasis and its associated symptoms.
Palliative effects of morinda citrifolia oil and juice
United States Patent 7018662
A method of preventing and treating various ailments and diseases by utilizing the Cox-2 selective inhibition characteristics of processed Morinda citrifolia.
Preventative and treatment effects of Morinda citrifolia on osteoarthritis and its related conditions
United States Patent 7033624
The present invention embraces methods for improved treatment of osteoarthritis by featuring a naturaceutical formulation or composition for treating osteoarthritis and its associated or related conditions. The present invention further features methods of treating osteoarthritis and its related conditions. In particular, the present invention relates to providing a treatment for osteoarthritis that includes one or more processed products described below as derived and produced from the Indian Mulberry plant, scientifically known as Morinda citrifolia L.
Formulation for treating candidiasis using Morinda citrifolia
United States Patent 7442395
The present invention features a formulation from the Indian mulberry plant (Morinda citrifolia ) comprising Morinda citrifolia fruit juice, Morinda citrifolia oil, quercetin, Morinda citrifolia puree juice and Morinda citrifolia dietary fiber treating Candidiasis.
sumber :freepatentsonline.com
Postingan
